[
  {
    "ts": null,
    "headline": "Labcorp Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72",
    "summary": "The board of Labcorp Holdings Inc. ( NYSE:LH ) has announced that it will pay a dividend on the 11th of September, with...",
    "url": "https://finnhub.io/api/news?id=e4589baa143ad43743515409ab3404ce8aa4d177a8f31453798527a79048877a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753896339,
      "headline": "Labcorp Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72",
      "id": 136149834,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "The board of Labcorp Holdings Inc. ( NYSE:LH ) has announced that it will pay a dividend on the 11th of September, with...",
      "url": "https://finnhub.io/api/news?id=e4589baa143ad43743515409ab3404ce8aa4d177a8f31453798527a79048877a"
    }
  },
  {
    "ts": null,
    "headline": "Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search",
    "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its-kind generative AI tool developed with Amazon Web Services (AWS). Designed to simplify lab test selection, Test Finder enables healthcare providers to ask questions or describe conditions in plain language and receive curated test recommendations—enhancing the user experience and freeing up more time for patient care.",
    "url": "https://finnhub.io/api/news?id=69e5df2f9778cb3e435f46d4a928a6b64f7a7e793cf8864daef37f179e03107b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753873920,
      "headline": "Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search",
      "id": 136130771,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its-kind generative AI tool developed with Amazon Web Services (AWS). Designed to simplify lab test selection, Test Finder enables healthcare providers to ask questions or describe conditions in plain language and receive curated test recommendations—enhancing the user experience and freeing up more time for patient care.",
      "url": "https://finnhub.io/api/news?id=69e5df2f9778cb3e435f46d4a928a6b64f7a7e793cf8864daef37f179e03107b"
    }
  },
  {
    "ts": null,
    "headline": "Pharma Formulation Development Outsourcing Forecast Report 2025-2033 Featuring SGS, Intertek, Recipharm, Lonza, Charles River Laboratories, Eurofins Scientific, Labcorp, Thermo Fisher Scientific",
    "summary": "The global Formulation Development Outsourcing Market is projected to grow from US$ 33.6 billion in 2024 to US$ 64.74 billion by 2033, at a CAGR of 7.56%. Key growth drivers include rising R&D costs, demand for specialized knowledge, complex regulations, and an expanding pharmaceutical industry. As pharmaceutical and biotech companies increasingly rely on contract development and manufacturing organizations (CDMOs) for integrated, end-to-end services, markets in North America, Europe, and the ra",
    "url": "https://finnhub.io/api/news?id=d5b478dc239482f4a68c45ce6a3fde2cb1632054ef994b3ec660d9a754d172df",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753867560,
      "headline": "Pharma Formulation Development Outsourcing Forecast Report 2025-2033 Featuring SGS, Intertek, Recipharm, Lonza, Charles River Laboratories, Eurofins Scientific, Labcorp, Thermo Fisher Scientific",
      "id": 136129913,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "The global Formulation Development Outsourcing Market is projected to grow from US$ 33.6 billion in 2024 to US$ 64.74 billion by 2033, at a CAGR of 7.56%. Key growth drivers include rising R&D costs, demand for specialized knowledge, complex regulations, and an expanding pharmaceutical industry. As pharmaceutical and biotech companies increasingly rely on contract development and manufacturing organizations (CDMOs) for integrated, end-to-end services, markets in North America, Europe, and the ra",
      "url": "https://finnhub.io/api/news?id=d5b478dc239482f4a68c45ce6a3fde2cb1632054ef994b3ec660d9a754d172df"
    }
  },
  {
    "ts": null,
    "headline": "Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic",
    "summary": "The global Drug Abuse Testing Market is set to surge, reaching $12.77 billion by 2033 from $6.64 billion in 2024, experiencing a CAGR of 7.54% between 2025-2033. This growth is driven by rising drug abuse rates, enhanced public awareness, and strict laws. Technological advancements in testing and an increased emphasis on preventative healthcare further boost the market. Key product and service segments include analyzers, rapid testing devices, and laboratory services, with urine tests dominating",
    "url": "https://finnhub.io/api/news?id=7fb19a3884e7caa6c6929cccbbce9cc63449259a8753cad5a3ddeaaabe0e0e43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753866480,
      "headline": "Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic",
      "id": 136129839,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "The global Drug Abuse Testing Market is set to surge, reaching $12.77 billion by 2033 from $6.64 billion in 2024, experiencing a CAGR of 7.54% between 2025-2033. This growth is driven by rising drug abuse rates, enhanced public awareness, and strict laws. Technological advancements in testing and an increased emphasis on preventative healthcare further boost the market. Key product and service segments include analyzers, rapid testing devices, and laboratory services, with urine tests dominating",
      "url": "https://finnhub.io/api/news?id=7fb19a3884e7caa6c6929cccbbce9cc63449259a8753cad5a3ddeaaabe0e0e43"
    }
  }
]